AVITA Medical, Inc. (AVHHL) — Insider Trading

AI-Powered SEC Filing Analysis

← All AVHHL filings

Want the newest filings?

This analysis covers the filing from 2026-02-23. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Earlier Insider Trading filings

Filed: 2026-02-19
  • The reporting person, Nicole Kelsey, was granted 98,390 restricted stock units (RSUs) and 145,060 stock options, indicating a grant of equity compensation to the Chief Legal Officer.
  • The RSUs and stock options vest over three years, aligning the reporting person's incentives with long-term shareholder value creation.
  • The grants suggest AVITA Medical is providing competitive compensation packages to retain and incentivize key executives like the Chief Legal Officer.
Filed: 2026-02-19
  • The reporting person, David O'Toole, acquired 105,470 shares of AVITA Medical, Inc. (AVHHL) common stock, increasing his direct beneficial ownership to 137,127 shares.
  • O'Toole was also granted 155,510 stock options with a strike price of $4.31 and a 10-year expiration, vesting in three equal annual installments starting on the first anniversary of the grant date.
  • The award of restricted stock units (RSUs) that vest over three years suggests a long-term incentive alignment between O'Toole and AVITA's shareholders.

Other reports for AVITA Medical, Inc.

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.